Masimo Corp
(BSP:M2AS34)
R$
39
+8.33 (+27.16%)
Market Cap: 2.04 Bil
Enterprise Value: 3.89 Bil
PE Ratio: 128.54
PB Ratio: 11.94
GF Score: 55/100 Masimo Corp at UBS Global Healthcare Conference (Virtual) Transcript
May 18, 2020 / 08:40PM GMT
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. Good afternoon. Thanks for joining us for a fireside chat session here in the med tech track with management from Masimo. I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst. And I am joined by Micah Young, the Chief Financial Officer of Masimo; and also Eli Kammerman, who runs the investor relations function and yes, works in the business development group as well. So guys, thanks a lot for joining us today for this fireside chat discussion here virtually.
Micah Young
Masimo Corporation - Executive VP of Finance & CFO
All right. Thank you, Matt.
Questions & Answers
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. All right. So just so everyone knows, I think at this point, they should, but if you have questions during the session, e-mail me or you can submit questions through the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot